Literature DB >> 24780100

Evolving renorrhaphy technique for retroperitoneal laparoscopic partial nephrectomy: single-surgeon series.

Wasilijiang Wahafu1, Xin Ma, Hong-Zhao Li, Qiang Ding, Bao-Jun Wang, Tao-Ping Shi, Tao Zheng, Jun Dong, Wei Cai, Xu Zhang.   

Abstract

OBJECTIVES: To evaluate renorrhaphy techniques and to analyze surgical outcomes in retroperitoneal laparoscopic partial nephrectomy.
METHODS: A retrospective study from January 2008 to December 2011 analyzed 526 patients with renal tumors in whom renorrhaphy was changed from one layer, interrupted, figure-of-eight (n = 228) suture to two layers, continuous, unknotted (n = 298) suture. All procedures were carried out by the same laparoscopic surgeon (XZ). Patient demographics, tumor characteristics, operative outcomes and perioperative renal function were compared.
RESULTS: Median follow up for one layer, interrupted, figure-of-eight suture and two layers, continuous, unknotted suture was 31 and 28 months, respectively. The two layers, continuous, unknotted suture group had shorter warm ischemia time (P = 0.021), faster removal of Jackson-Pratt drains (P = 0.029) and shorter hospital stay (P = 0.037) than the one layer, interrupted, figure-of-eight suture group. There was a trend towards a better preservation of glomerular filtration rates in the two layers, continuous, unknotted suture group (P = 0.045). In a multivariable model, the two layers, continuous, unknotted suture technique was a statistically significant independent predictor of warm ischemia time (P = 0.01), hospital stay (P = 0.001) and estimated glomerular filtration rates (P = 0.043).
CONCLUSIONS: Two layers, continuous, unknotted suture renorrhaphy allows better outcomes than one layer, interrupted, figure-of-eight suture renorrhaphy in retroperitoneal laparoscopic partial nephrectomy. A longer clinical follow-up evaluation is warranted.
© 2014 The Japanese Urological Association.

Entities:  

Keywords:  outcomes; partial nephrectomy; renal tumors; renorrhaphy; retroperitoneal laparoscopy

Mesh:

Year:  2014        PMID: 24780100     DOI: 10.1111/iju.12470

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  6 in total

1.  Surgical innovation revisited: A historical narrative of the minimally invasive "Agarwal sliding-clip renorrhaphy" technique for partial nephrectomy and its application to an Australian cohort.

Authors:  A W Silagy; R Young; B D Kelly; F Reeves; M Furrer; A J Costello; B J Challacombe; N M Corcoran; J Kearsley; P Dundee; D K Agarwal
Journal:  BJUI Compass       Date:  2021-03-12

2.  Comparison of Transperitoneal and Retroperitoneal Robotic Partial Nephrectomy for Patients With Complete Upper Pole Renal Tumors.

Authors:  Liangyou Gu; Wenlei Zhao; Junnan Xu; Baojun Wang; Qiang Cheng; Donglai Shen; Yundong Xuan; Xupeng Zhao; Hongzhao Li; Xin Ma; Xu Zhang
Journal:  Front Oncol       Date:  2022-01-25       Impact factor: 6.244

3.  A Modified Two-Layer Suture Technique for Transperitoneal Laparoscopic Partial Nephrectomy: Single-Center Clinical Experience.

Authors:  Yang Jin; Hui Xiong; Qinghua Xia; Qi Zhang
Journal:  Front Surg       Date:  2022-02-01

4.  The clinical application of the sliding loop technique for renorrhaphy during robot-assisted laparoscopic partial nephrectomy: Surgical technique and outcomes.

Authors:  Hyung Suk Kim; Young Ju Lee; Ja Hyeon Ku; Cheol Kwak; Hyeon Hoe Kim; Chang Wook Jeong
Journal:  Korean J Urol       Date:  2015-11-03

5.  Retroperitoneoscopic partial nephrectomy for renal cell carcinoma: A single-center Indian experience.

Authors:  Suresh Kumar; Pranjal R Modi; Bipin C Pal; Vivek Kothari; Amit Mishra
Journal:  Urol Ann       Date:  2018 Oct-Dec

6.  Robot-assisted laparoscopic partial nephrectomy is a safe and effective option for clinical T2 renal cell carcinoma: a case-series from single-institution.

Authors:  Gongwei Long; Man Liu; Yucong Zhang; Guoliang Sun; Wei Ouyang; Jun Yang; Zhihua Wang; Zheng Liu; Wei Guan; Zhiquan Hu; Shaogang Wang; Heng Li
Journal:  Transl Cancer Res       Date:  2020-11       Impact factor: 1.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.